New medication combined with standard treatment for stomach lymphoma

This trial is testing whether a medication called orelabrutinib, when combined with standard antibiotics that kill the bacteria causing the lymphoma, works better than antibiotics alone. The study focuses on people who have a rare type of stomach lymphoma linked to a Helicobacter pylori infection. Researchers want to see if adding this medication helps more patients recover.

Currently, doctors treat this type of lymphoma by giving antibiotics to eliminate the bacterial infection, and many patients do recover. However, some patients don't respond well to antibiotics alone, so researchers are testing whether the new treatment can help more people—particularly those whose lymphoma might not go away with standard care alone.